{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:47:41Z","timestamp":1790095661887,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670583"],"award-info":[{"award-number":["81670583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30GM110759"],"award-info":[{"award-number":["P30GM110759"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA123544"],"award-info":[{"award-number":["CA123544"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.canlet.2020.02.039","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T11:42:43Z","timestamp":1583322163000},"page":"63-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis"],"prefix":"10.1016","volume":"481","author":[{"given":"Kosuke","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuliang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinggang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8895-2123","authenticated-orcid":false,"given":"Songhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-8754","authenticated-orcid":false,"given":"Rolf","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Safran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1731-624X","authenticated-orcid":false,"given":"Jack","family":"Wands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.02.039_bib1","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2020.02.039_bib2","doi-asserted-by":"crossref","first-page":"39543","DOI":"10.1074\/jbc.M006753200","article-title":"Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin","volume":"275","author":"Dinchuk","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.02.039_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development","volume":"284","author":"Artavanis-Tsakonas","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.canlet.2020.02.039_bib4","first-page":"1261","article-title":"Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation","volume":"60","author":"Ince","year":"2000","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.039_bib5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI118918","article-title":"Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma","volume":"98","author":"Lavaissiere","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2020.02.039_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.23650","article-title":"Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome","volume":"52","author":"Wang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2020.02.039_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.18632\/oncotarget.2840","article-title":"Aspartate beta-Hydroxylase expression promotes a malignant pancreatic cellular phenotype","volume":"6","author":"Dong","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.02.039_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(03)00052-7","article-title":"Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells","volume":"38","author":"Maeda","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2020.02.039_bib9","first-page":"881","article-title":"Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility, Laboratory investigation","volume":"82","author":"Sepe","year":"2002","journal-title":"J. Tech. Methods Pathol."},{"key":"10.1016\/j.canlet.2020.02.039_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.humpath.2008.11.001","article-title":"Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase\/humbug expression in non-small cell lung carcinoma","volume":"40","author":"Luu","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2020.02.039_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.humpath.2006.07.009","article-title":"Prognostic value of humbug gene overexpression in stage II colon cancer","volume":"38","author":"Wang","year":"2007","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2020.02.039_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/hep.21272","article-title":"Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms","volume":"44","author":"Cantarini","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2020.02.039_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.09.016","article-title":"Activation of signal transduction pathways during hepatic oncogenesis","volume":"370","author":"Chung","year":"2016","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.02.039_bib14","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.27275","article-title":"A cell-surface beta-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma","volume":"60","author":"Aihara","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2020.02.039_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.27081","article-title":"WNT\/beta-catenin signaling and hepatocellular carcinoma","volume":"60","author":"Wands","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2020.02.039_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/liv.12188","article-title":"Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma","volume":"33","author":"Tomimaru","year":"2013","journal-title":"Liver Int. : Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.canlet.2020.02.039_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.02.039_bib18","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1242\/jcs.064386","article-title":"Microvesicles: mediators of extracellular communication during cancer progression","volume":"123","author":"Muralidharan-Chari","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2020.02.039_bib19","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1158\/0008-5472.CAN-12-0925","article-title":"Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression","volume":"72","author":"Bobrie","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.039_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2020.02.039_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13045-019-0837-z","article-title":"Aspartate beta-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway","volume":"12","author":"Ogawa","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2020.02.039_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12943-019-1077-0","article-title":"ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis","volume":"18","author":"Lin","year":"2019","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2020.02.039_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.09.051","article-title":"Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways","volume":"159","author":"Boelens","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.02.039_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.02.039_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbior.2014.10.002","article-title":"Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes","volume":"57","author":"Shamseddine","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.canlet.2020.02.039_bib26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2020.02.039_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.4586","article-title":"Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis","volume":"237","author":"Brown","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2020.02.039_bib28","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1128\/MCB.00116-15","article-title":"Notch1 autoactivation via transcriptional regulation of furin, which sustains Notch1 signaling by processing Notch1-activating proteases ADAM10 and membrane type 1 matrix metalloproteinase","volume":"35","author":"Qiu","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2020.02.039_bib29","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1074\/jbc.M113.516039","article-title":"Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation","volume":"289","author":"Ma","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.02.039_bib30","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.celrep.2013.10.050","article-title":"Exosome secretion is enhanced by invadopodia and drives invasive behavior","volume":"5","author":"Hoshino","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2020.02.039_bib31","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.jprot.2010.06.006","article-title":"Exosomes: extracellular organelles important in intercellular communication","volume":"73","author":"Mathivanan","year":"2010","journal-title":"J. Proteom."},{"key":"10.1016\/j.canlet.2020.02.039_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ncb2647","article-title":"Rab10 GTPase regulates ER dynamics and morphology","volume":"15","author":"English","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2020.02.039_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0854.2004.00257.x","article-title":"Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner","volume":"6","author":"Savina","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.canlet.2020.02.039_bib34","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-723","article-title":"Improved detection of cancer specific serum exosomal aspartyl (asparaginyl) beta hydroxylase (HAAH)","volume":"77","author":"Semenuk","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.02.039_bib35","doi-asserted-by":"crossref","first-page":"39521","DOI":"10.18632\/oncotarget.3999","article-title":"Novel agents for advanced pancreatic cancer","volume":"6","author":"Akinleye","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.02.039_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.02.039_bib37","article-title":"Anti-tumor effects of second generation beta-hydroxylase inhibitors on cholangiocarcinoma development and progression","volume":"11","author":"Huang","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2020.02.039_bib38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.28411","article-title":"Aspartate beta-hydroxylase modulates cellular senescence through glycogen synthase kinase 3beta in hepatocellular carcinoma","volume":"63","author":"Iwagami","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2020.02.039_bib39","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.vaccine.2015.01.037","article-title":"Aspartate-beta-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma","volume":"33","author":"Tomimaru","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.canlet.2020.02.039_bib40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jhep.2011.12.016","article-title":"Tumor progression-related transmembrane protein aspartate-beta-hydroxylase is a target for immunotherapy of hepatocellular carcinoma","volume":"56","author":"Shimoda","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2020.02.039_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.24629","article-title":"Immunization with aspartate-beta-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma","volume":"55","author":"Noda","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2020.02.039_bib42","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2006.01.038","article-title":"Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness","volume":"44","author":"de la Monte","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2020.02.039_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cdp.2004.06.001","article-title":"Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma","volume":"28","author":"Maeda","year":"2004","journal-title":"Canc. Detect. Prev."},{"key":"10.1016\/j.canlet.2020.02.039_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006676-200207000-00010","article-title":"Human aspartyl (asparaginyl) beta-hydroxylase monoclonal antibodies: potential biomarkers for pancreatic carcinoma","volume":"25","author":"Palumbo","year":"2002","journal-title":"Pancreas"}],"updated-by":[{"DOI":"10.1016\/j.canlet.2025.218119","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520301087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520301087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:45:18Z","timestamp":1768445118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520301087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":44,"alternative-id":["S0304383520301087"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.02.039","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}